Stay updated on Pembrolizumab Post-Tx in Oligometastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Post-Tx in Oligometastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Post-Tx in Oligometastatic NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page’s platform/site revision label was updated from **v3.5.2** to **v3.5.3**, reflecting a behind-the-scenes release rather than a change to the clinical trial record.
    Difference
    0.1%
    Check dated 2026-04-26T15:20:16.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Added revision: v3.5.2; removed revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-19T13:30:37.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-03-21T16:55:38.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-07T06:49:50.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    The site version badge updated from v3.4.1 to v3.4.2, indicating a backend/frontend revision. No study content or functionality was changed as part of this update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T17:31:15.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The only visible change is the footer revision updated from v3.4.0 to v3.4.1, and the main content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T12:06:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Post-Tx in Oligometastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Post-Tx in Oligometastatic NSCLC Clinical Trial page.